Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lcr Regenerans for Intermediate Vaginal Microbiota in Pregnancy
NCT02979288Phase 3Completed
- Sponsor
- Medical University of Vienna
- Start
- May 2017
- Primary completion
- Nov 2020
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of lactobacillus casei + lactobacillus rhamnosus in Vaginal dysbiosis and preterm birth (4 arms), sponsored by Medical University of Vienna. Primary endpoint: Recovery to normal vaginal microbiota (Nugent score 0 to 3) at 4 weeks. Started May 2017; status: completed.
02
Drugs
lactobacillus casei + lactobacillus rhamnosus
03
Conditions
Vaginal dysbiosispreterm birth
Beyond the preview
Go deeper on NCT02979288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02979288.